Sign inJoin waitlistJoin the waitlist

Jeffery Bednarski

Division Director, Pediatric Hematology, Oncology and Stem Cell Transplantation · Univ of Pittsburgh Sch of Med

Credentials: · · · · ·

History

Washington Univ Sch of Med
Present
Univ of Pittsburgh Sch of Med
Present

Hematology and Medical Oncology
Washington University School of Medicine
2006–2009
Pediatrics
St Louis Children's Hospital
2003–2006
University of Michigan Medical School
1999–2003
Duke University
1991–1995

Research

DNA double-strand breaks induce H2Ax phosphorylation domains in a contact-dependent manner
Nature Communications · 2020 · 183 citations
Function of the htrB high temperature requirement gene of Escherichia coli in the acylation of lipid A: HtrB catalyzed incorporation of laurate
Journal of Biological Chemistry · 1996 · 159 citations
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery
Blood · 2018 · 146 citations

Michael Pulsipher
17 papers
Sung-Yun Pai
17 papers
Christopher Dvorak
16 papers
Donald Kohn
16 papers
Jennifer Heimall
15 papers · 4 as a fellow
JL
Jennifer Leiding
15 papers
Jennifer Puck
15 papers
LG
Linda Griffith
15 papers
Luigi Notarangelo
15 papers
Morton Cowan
15 papers
NK
Neena Kapoor
15 papers
Blachy Saldaña
14 papers

Grants

RAG-Mediated DNA Damage Responses in Immune Development and Function
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2.5M · University of Pittsburgh at Pittsburgh
2022–2027
MYSM1-Dependent DNA Damage Responses in Early B Cell Development
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $430.4K · Washington University
2022–2025
Role of DNA Damage Responses in Immune Development and Function
National Institute of Allergy and Infectious Diseases · R56
Contact PI · $315K · Washington University
2020–2022
Integration of Dna Damage Responses with Immune Development and Function
National Institute of Allergy and Infectious Diseases · K08
Contact PI · $634.2K · Washington University
2012–2017

Clinical trials

Cytokine-induced Memory-like NK Cells in Combination With Chemotherapy in Pediatric Patents With Refractory or Relapsed AML
Principal investigator · Withdrawn · Phase 2
Washington University School of Medicine
2023–2028